Multiple Myeloma Treatment in India – VRd, ASCT & Daratumumab

Multiple myeloma treatment in India from $10,000. Bortezomib-lenalidomide-dexamethasone (VRd), autologous stem-cell transplant, and daratumumab at expert haematology centres.

Estimated cost: $10,000 – $35,000 · Average stay: 14–45 days

Comprehensive guide to Multiple Myeloma Treatment — a hematology treatment available through GAF Healthcare's network of internationally accredited hospitals.

See the full treatment guide on the public site for detailed sections on procedure, costs, recovery, and FAQs.